Cargando…
Subversion of the chemotherapy-induced anticancer immune response by the ecto-ATPase CD39
The efficacy of antineoplastic chemotherapies with anthracyclines or oxaliplatin relies on the induction of immunogenic cell death, thus provoking an anticancer immune response. Recently, we observed that overexpression of CD39, an ATP-degrading enzyme expressed on the cell surface, abolishes the im...
Autores principales: | Michaud, Mickaël, Sukkurwala, Abdul Qader, Martins, Isabelle, Shen, Shensi, Zitvogel, Laurence, Kroemer, Guido |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382873/ https://www.ncbi.nlm.nih.gov/pubmed/22737627 http://dx.doi.org/10.4161/onci.19070 |
Ejemplares similares
-
Anticancer activity of cardiac glycosides: At the frontier between cell-autonomous and immunological effects
por: Kepp, Oliver, et al.
Publicado: (2012) -
ATP-dependent recruitment, survival and differentiation of dendritic cell precursors in the tumor bed after anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2013) -
Chemokines and chemokine receptors required for optimal responses to anticancer chemotherapy
por: Ma, Yuting, et al.
Publicado: (2014) -
An anticancer therapy-elicited immunosurveillance system that eliminates tetraploid cells
por: Senovilla, Laura, et al.
Publicado: (2013) -
Synthetic induction of immunogenic cell death by genetic stimulation of endoplasmic reticulum stress
por: Michaud, Mickaël, et al.
Publicado: (2014)